Endoscopic resection is often feasible for submucosal invasive colorectal cancers (T1-CRCs) and usually judged as complete. If histology casts doubt on the radicality of resection margins, adjuvant surgical resection is advised, although, residual intramural cancer (RIC) is found in only 5% to 15% of patients. We assessed sensitivity of biopsies from the resection area for RIC as a potential tool to estimate the preoperative risk of RIC in patients without risk factors for lymph node metastasis (LNM).
In this multicenter prospective cohort study, patients with complete endoscopic resection of a T1-CRC, scheduled for adjuvant resection due to pathologically unclear resection margins, but absent risk factors for LNM, were asked to consent for second-look endoscopy with biopsies. The results were compared with pathology results of the surgical resection specimen (criterion standard).
One hundred three patients were included. In total, 85% of resected lesions were unexpectedly malignant, and 45% removed using a piecemeal resection technique. Sixty-four adjuvant surgical resections and 39 local full-thickness resections were performed. RIC was found in 7 patients (6.8%). Two of these patients had cancer in second-look biopsies, resulting in a sensitivity of 28% (95% CI, <58%). The preoperative risk of residual intramural cancer in case of negative biopsy specimens was not significantly reduced (p = 0.61).
Sensitivity of second-look endoscopy with biopsies for residual intramural cancer after endoscopic resection of CRC is low. Therefore, it should not be used in the decision whether or not to perform adjuvant resection. https://clinicaltrials.gov/show/NCT02328664.
Copyright © 2020 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
Related Posts
An update on the association between traumatic brain injury and Alzheimer’s disease : focus on tau pathology and synaptic dysfunction.
November 12, 2020
A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient’s population in North Central Nigeria.
September 3, 2020
Advertisement
Meeting Coverage
- ASCO – Lung CancerASCO.20 Virtual Scientific Program, held May 29 - 31, brought professionals from all over the world together to hear the brightest minds in oncology present state-of-the-art treatment modalities and new therapies.
- AACR-2020The American Association for Cancer Research is the world's oldest and largest professional association related to cancer research.
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ASCO 2019The 2019 ASCO Annual Meeting, taking place May 31-June 4 in Chicago, will bring together more than 32,000 oncology professionals from across the globe. The theme of this year’s conference is Caring for Every Patient, Learning From Every Patient.